CollPlant Biotechnologies (CLGN) Shares Outstanding (Weighted Average) (2017 - 2025)

CollPlant Biotechnologies has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $12.2 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 6.54% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (up 6.54% YoY), and the FY2025 full-year result was $12.2 million, up 6.54% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $12.2 million, down from $11.8 billion in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $11.8 billion in Q2 2025, with the low at $186000.0 in Q4 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $5.0 billion across 5 years, with a median of $12.2 million in 2025.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) slumped 100.0% — and 2023, when it jumped 4508279.2%.
• CollPlant Biotechnologies' Shares Outstanding (Weighted Average) stood at $10.0 million in 2021, then sank by 95.74% to $425000.0 in 2022, then slumped by 56.24% to $186000.0 in 2023, then soared by 6058.16% to $11.5 million in 2024, then grew by 6.54% to $12.2 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $12.2 million (Q4 2025), $11.8 billion (Q2 2025), and $11.5 million (Q4 2024), per Business Quant data.